Increased colistin resistance of Acinetobacter species in intensive care unit-acquired infections in a tertiary care hospital

Increased colistin resistance

Authors

  • Sanem Karadag Gecgel Bursa Yuksek Ihtisas Training and Research Hospital
  • Canan Demir

DOI:

https://doi.org/10.3823/815

Keywords:

Colistin, Intensive care unit, Acinetonacter baumannii antibiotic resistance

Abstract

Background: The aim of our study was to evaluate the antimicrobial resistance rates among pathogen microorganisms especially colistin resistant rates of Acinetobacter baumannii in intensive care unit (ICU)-acquired infections and to determine infection-specific correct treatment strategies.

Methods: The data of adult and newborn infant patients diagnosed with ICU-acquired infection in a tertiary education and research hospital in Bursa in 2014 and 2016 were analyzed, retrospectively.

Results: Acinetobacter baumannii was the most frequent pathogen of ICU-acquired infections in 2014 and 2016. There was a significant increase in colistin (CO) resistance rates in A. baumanii (0.0%-6.8%). A significant increase in CO, cefepime (FEP), ciprofloxacin (CIP) resistance rates was established in all gram negative bacteria (0.0%-7.9%, 50.0%-91.9%, 54.7%-74.6%), respectively. A significant increase in the rate of detection of A. baumanii as the pathogen microorganism in respiratory tract infection (RTI) was established (53.9% -79.5%). In addition, the average ventilator-associated pneumonia (VIP) infection rate also increased in 2016 compared to 2014 (VIP rate 2014: 7.12, 2016: 7.45, per 1000 ventilator days). A significant decrease in the rate of detection of all gram negative microorganisms in the surgical site infection (SSI), and a significant increase in the rate of detection of all gram positive microorganisms in the SSI was determined.

Conclusion: Increased antimicrobial resistance, especially increased colistin resistance rates in ICU-acquired infections, necessitates the creation of new strategies in empirical therapy. Detection of antimicrobial resistance profiles of local and infectious pathogen microorganisms in ICUs is a good guide for correct antimicrobial management.

References

References

Mitharwal SM, Yaddanapudi S, Bhardwaj N, Gautam V, Biswal M, et al. Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes. Am J Infect Control 2016; 44: 113-7.

Ariffin N, Hasan H, Ramli N, Ibrahim NR, Taib F, et al. Comparison of antimicrobial resistance in neonatal and adult intensive care units in a tertiary teaching hospital. Am J Infect Control 2012; 40: 572-5.

Axente C, Licker M, Moldovan R, Hogea E, Muntean D, Horhat F, Bedreag O, Sandesc D, Papurica M, Dugaesescu D, Voicu M, Baditoiu L. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit. BMC Infect Dis. 2017; 17: 358. doi: 10.1186/s12879-017-2440-7.

Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin 2011; 27: 163-205.

Ritchie DJ, Alexander BT, Finnegan PM. New antimicrobial agents for use in the intensive care unit. Infect Dis Clin North Am 2009; 23: 665-81.

Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol 2014; 5: 551.

Yilmaz GR, Dizbay M, Guven T, Pullukcu H, Tasbakan M, et al. Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study. Ann Saudi Med 2016; 36: 216-22.

Lee JY, Choi MJ, Choi HJ, Ko KS. Preservation of acquired colistin resistance in gram-negative bacteria. Antimicrob Agents Chemother2015; 60: 609-12.

Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CM. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother 2013; 57: 3224-9.

Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings. MMWR Morb Mortal Wlkly Rep. 2002; 51: 343.

Beardsley J, Williamson J, Johnson J, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital acquired pneumonia. Chest 2006;130:787-93.

Arroyo LA, Garcia-Curiel A, Pachon- Ibanez ME, van den Barselaar M, Nordmann P, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 903-5.

Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012; 67: 1607-15.

Beriş FŞ, Budak EE, Gülek D, Uzun A, Çizmeci Z, et aal. Investigation of the frequency and distribution of beta-lactamase genes in the clinical isolates of Acinetobacter baumannii collected from different regions of Turkey: a multicenter study. Mikrobiyol Bul 2016; 50: 511-21.

Karagöz A, Baran I, Aksu N, Acar S, Durmaz R. Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures. Mikrobiyol Bul 2014; 48: 566-76.

Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015; 37: 129-34.

Clark NM, Patterson J, Lynch JP. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003; 9: 413-23.

Shojaei L, Mohammadi M, Beigmohammadi MT, Doomanlou M, Abdollahi A, et al. Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients. Iran J Microbiol. 2016; 8: 288-29.

Gu WJ, Wang F, Tang L, Bakker J, Liu JC. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis. Int J Antimicrob Agents 2014; 44: 477-85.

Tekin R, Dal T, Pirinccioglu H, Oygucu SE. A 4-year surveillance of device-associated nosocomial infections in a neonatal intensive care unit. Pediatr Neonatol 2013; 54: 303-8.

El-Saed A, Balkhy HH, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM. Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis. 2013; 17: 696-701.

Leblebicioglu H, Erben N, Rosenthal VD, Atasay B, Erbay A, et al. International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012. Ann Clin Microbiol Antimicrob 2014: 18; 13:51.

Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008; 36: 1-12.

Downloads

Published

2017-12-31

Issue

Section

Articles